COGT News and Press, Cogent Biosciences Inc Com From 08/17/22

Gainers: Blue Water Vaccines ( BWV ) +57% . Eargo ( EAR ) +49% . Cassava Sciences ( SAVA ) +29% . MiNK Therapeutics ( INKT ) +24% . Cogent Biosciences ( COGT ) +16% . Losers: Blueprint Medicines ( BPMC ) -22% ....

Cogent Biosciences press release ( NASDAQ: COGT ): Q2 GAAP EPS of -$0.71 misses by $0.05 . As of June 30, 2022, cash and cash equivalents were $325.6 million, as compared to $191.0 million as of March 31, 2022. The company believes that its cash and cash equivalen...

On-track to present additional data from Phase 2 APEX trial by the end of 2022 Initial data from Phase 2 SUMMIT trial & lead-in data from Phase 3 PEAK trial planned for 1H23 Ended 2Q 2022 with $325.6 million , including $172.6 million in gross proceeds from J...

Cogent has a single molecule in various trials. Recently, they produced some positive early data. We should be able to get a better grasp on the company in about a year. For further details see: Cogent Biosciences: APEX Data Was Interesting, But We Need More

Up 120.4% to $9.61, Cogent Biosciences Inc. (NGS:COGT), is one of today's notable movers. In the past 52 weeks, Cogent Biosciences Inc. share prices are bracketed by a low of $3.79 and a high of $11.06 and is now at $9.61, 154% above that low price. Receive IBN Spotlights - "Bite Size"...

One of today's notable stocks on the rise is Cogent Biosciences Inc. (NGS:COGT), up 116.7% to $9.45. In the past 52 weeks, shares of Cogent Biosciences Inc. have traded between a low of $3.79 and a high of $11.06 and is now at $9.45, which is 149% above that low price. Receive IBN Spot...

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its upsized underwritten public offering of ...

Cogent Biosciences (NASDAQ:COGT) priced an underwritten public offering of 15.17M shares offered at a public offering price of $8.25/share. The company is also offering pre-funded warrants to purchase 3.03M shares at a purchase price of $8.24/pre-funded warrant. Underwriters granted 30-d...

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of an underwritten public offering of 15,169,69...

MicroStrategy (MSTR) -25% as crypto market cap sinks below $1T. Astra Space (ASTR) -25% after latest mission failure. Qutoutiao (QTT) -21%. Marathon Digital Holdings (MARA) -17% as crypto market cap sinks below $1T. Bitfarms (BITF) -17% as cry...